ArrowMark Colorado Holdings’s Blueprint Medicines BPMC Stock Holding History

ArrowMark Colorado Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,135	Closed	-$287K	–	342
2018 Q1	$287K	Hold	3,135	–	–	﹤0.01%	313
2017 Q4	$236K	Sell	3,135 -170	-5%	-$12K	﹤0.01%	324
2017 Q3	$230K	Buy	+3,305	New	+$177K	﹤0.01%	323
2016 Q4	–	Sell	-3,900	Closed	-$116K	–	317
2016 Q3	$116K	Buy	+3,900	New	+$96.9K	﹤0.01%	287
2015 Q4	–	Sell	-73,360	Closed	-$1.57M	–	269
2015 Q3	$1.57M	Sell	73,360 -5,252	-7%	-$145K	0.04%	206
2015 Q2	$2.08M	Buy	+78,612	New	+$2.25M	0.05%	213

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ArrowMark Colorado Holdings's BPMC Position: Q2 2018 in Review

ArrowMark Colorado Holdings sold out of Blueprint Medicines (BPMC) in Q2 2018, closing a stake of 3,135 shares — an estimated $287K sold.

ArrowMark Colorado Holdings first reported a position in BPMC in Q2 2015 and held it in 6 quarters. The position peaked at $2.08M in Q2 2015. 181 funds tracked by Wall St. Rank hold BPMC as of Q2 2018.

ArrowMark Colorado Holdings reported no remaining Blueprint Medicines position as of Q2 2018 after selling out during the quarter.
ArrowMark Colorado Holdings sold 3,135 Blueprint Medicines shares in Q2 2018, an estimated $287K.
ArrowMark Colorado Holdings first reported a position in Blueprint Medicines in Q2 2015 and held it in 6 quarters.
ArrowMark Colorado Holdings's Blueprint Medicines position peaked at $2.08M in Q2 2015.
181 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2018.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.